1257629-21-2

Basic information

• Product Name: C₁₈H₁₅BrN₂O₃
• CAS NO: 1257629-21-2
• Molecular Weight: 387.233
• Mol File: 1257629-21-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₁₈H₁₅BrN₂O₃(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₈H₁₅BrN₂O₃(1257629-21-2)
• EPA Substance Registry System: C₁₈H₁₅BrN₂O₃(1257629-21-2)

Safety Data

• Hazardous Substances Data: 1257629-21-2(Hazardous Substances Data)

Upstream product

• 5794-88-7 5-Bromo-2-aminobenzoic acid 
• 98-88-4 benzoyl chloride 
• 27398-50-1 6-bromo-2-phenyl-3H,4H-quinazolin-4-one 
• 105-39-5 chloroacetic acid ethyl ester 
• 66387-70-0 6-bromo-2-phenyl-4H-benzo[2,3-d]-1,3-oxazin-4-one 

Downstream Products

• 1257629-22-3 [(6-bromo-2-phenyl-4-quinazolinyl)oxy]-acetyl hydrazine 
• 1257629-15-4 C₂₀H₁₅BrN₄O₃ 
• 1257629-17-6 6-bromo-4-(1,3,4-oxadiazol-2-ylmethoxy)-2-phenylquinazoline 
• 1257629-18-7 5-{[(6-bromo-2-phenylquinazolin-4-yl)oxy]methyl}-1,3,4-oxadiazol-2(3H)-thione 
• 1257629-20-1 5-{[(6-bromo-2-phenylquinazolin-4-yl)oxy]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-thione 

Relevant articles and documents

Synthesis, antimicrobial evaluation, and docking studies of novel 4-substituted quinazoline derivatives as DNA-gyrase inhibitors

Quinazoline derivatives are reported to have anti-inflammatory, analgesic, antibacterial, and anticancer activities. The incorporation of "OCH 2CONH2" (oxymethylcarbamide) at 4th position of the quinazoline ring was found